Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Susaki

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|December 23, 1998
Renal drug targeting using a vector "alkylglycoside"K Suzuki, H Susaki, S Okuno, et al.
Analytical Sciences : the International Journal of the Japan Society for Analytical Chemistry|May 7, 2002
Fluorescent derivatization of nitrite ions with 2,3-diaminonaphthalene utilizing a pH gradient in a Y-shaped microchannelT Odake, M Tabuchi, T Sato, et al.
Chemical & Pharmaceutical Bulletin|October 1, 1994
Synthesis of artificial glycoconjugates of arginine-vasopressin and their antidiuretic activitiesH Susaki, K Suzuki, M Ikeda, et al.
Chemical & Pharmaceutical Bulletin|November 12, 1998
Synthesis and antidiuretic activities of novel glycoconjugates of arginine-vasopressinH Susaki, K Suzuki, M Ikeda, et al.
Biological & Pharmaceutical Bulletin|November 5, 1999
Renal targeting of arginine-vasopressin by modification with carbohydrates at the tyrosine side chainH Susaki, K Suzuki, H Yamada, et al.
Pharmaceutical Research|August 18, 1999
Structural requirements for alkylglycoside-type renal targeting vectorK Suzuki, T Ando, H Susaki, et al.
Biological & Pharmaceutical Bulletin|February 1, 1994
Tissue-targeting ability of saccharide-poly(L-lysine) conjugatesA Gonsho, K Irie, H Susaki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 1, 1989
[Influence of OK-432 on intratumor 5-fluorouracil concentration in cases given UFT]K Sinmyo, H Hosoi, H Suwa, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 26, 1999
Specific renal delivery of sugar-modified low-molecular-weight peptidesK Suzuki, H Susaki, S Okuno, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
The Journal of Pharmacology and Experimental Therapeutics|December 23, 1998
Renal drug targeting using a vector "alkylglycoside"K Suzuki, H Susaki, S Okuno, et al.
Analytical Sciences : the International Journal of the Japan Society for Analytical Chemistry|May 7, 2002
Fluorescent derivatization of nitrite ions with 2,3-diaminonaphthalene utilizing a pH gradient in a Y-shaped microchannelT Odake, M Tabuchi, T Sato, et al.
Chemical & Pharmaceutical Bulletin|October 1, 1994
Synthesis of artificial glycoconjugates of arginine-vasopressin and their antidiuretic activitiesH Susaki, K Suzuki, M Ikeda, et al.
Chemical & Pharmaceutical Bulletin|November 12, 1998
Synthesis and antidiuretic activities of novel glycoconjugates of arginine-vasopressinH Susaki, K Suzuki, M Ikeda, et al.
Biological & Pharmaceutical Bulletin|November 5, 1999
Renal targeting of arginine-vasopressin by modification with carbohydrates at the tyrosine side chainH Susaki, K Suzuki, H Yamada, et al.
Pharmaceutical Research|August 18, 1999
Structural requirements for alkylglycoside-type renal targeting vectorK Suzuki, T Ando, H Susaki, et al.
Biological & Pharmaceutical Bulletin|February 1, 1994
Tissue-targeting ability of saccharide-poly(L-lysine) conjugatesA Gonsho, K Irie, H Susaki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 1, 1989
[Influence of OK-432 on intratumor 5-fluorouracil concentration in cases given UFT]K Sinmyo, H Hosoi, H Suwa, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 26, 1999
Specific renal delivery of sugar-modified low-molecular-weight peptidesK Suzuki, H Susaki, S Okuno, et al.
Pageof 1